Compare Intanwijaya Internasional Tbk (INCI) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intanwijaya Internasional Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Intanwijaya Internasional Tbk trades at Rp675 (market cap 139.13B, 16.4K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 90.4× Intanwijaya Internasional Tbk's market cap, and Tempo Scan Pacific Tbk. is more actively traded (235.2K versus 16.4K). Which is the better fit depends on your goals.
| INCI | TSPC | |
|---|---|---|
Market Cap | 139.13B | 12.58T |
Volume | 16.4K | 235.2K |
Lot | 164 | 2.35K |
Turnover | 11.11M | 649.94M |
Average Price | 677.56 | 2,763.37 |
Value | 11.11M | 649.94M |
Indicative Equilibrium Price | — | 2,780 |
Indicative Equilibrium Volume | — | 9 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intanwijaya Internasional Tbk
PT Intanwijaya International Tbk (the Company) formerly named as PT Intan Wijaya Chemical Industry Tbk, was established in Jakarta based on the Notarial Deed No. 64 of Jony Frederik Berthold Tumbelaka Sinjal, S.H., dated November 14, 1981.The company's business field in in the Formaldehyde and Formaldehyde Resin Industries with the capacity of 96.000 metrics tons per annum in the form of liquid and 7.000 metric tons per annum in the form of powder and Hexamine 6.000 metric tons per annum.
Read more on INCI →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
